Table 2.

Demographics of Patients With Culture-Proven Viral Pneumonia Treated With ECLS

	n	Age (mo)	Weight (kg)	Male/Female (n)
RSV	81	3.6 ± 0.4 (3.0)	3.72 ± 0.19	43/38
HSV	13	1.2 ± 1.0 (0.13)	3.35 ± 0.39	5/8
Adenovirus	12	4.4 ± 1.9 (0.6)	5.02 ± 1.00	9/3
CMV	9	6.9 ± 2.9 (2.5)	5.90 ± 0.99†	5/4
Other	12	15.4 ± 5.8 (5.5)*	8.14 ± 1.41*	7/5
*P<.05 versus all other groups. †P<.05 versus RSV and HSV groups.

NOTE. The group termed “other” consists of patients with varicella, influenza, parainfluenza, and enterovirus. Data are means ± SEM.

Numbers in parentheses are medians.

Abbreviation: ECLS, extracoporeal life support.

Adapted with permission.³